Retinal Scans: A Non-Invasive Tool for Cardiovascular Health and Biological Aging

A study published in the journal Science Advances on October 24, 2025, suggests that simple retinal scans could be used in the future as a non-invasive tool to assess cardiovascular health and biological aging. These scans could help doctors detect problems early and guide preventive care before symptoms appear.

Connecting Eyes, Genes, and Blood

Mary Beiger, the lead author of the study and an assistant professor in the Department of Medicine at McMaster University, explained that retinal scans, genes, and blood biomarkers reveal molecular pathways that help explain how aging affects the vascular system. The eye provides a unique and accessible view of the body’s circulatory system, as changes in retinal blood vessels often reflect changes occurring in small blood vessels throughout the body.

To explore these relationships, researchers analyzed retinal images, genetic profiles, and blood samples from more than 74,000 participants across four large-scale studies: the Canadian Longitudinal Study on Aging, the Tayside Diabetes Genes Study, the UK Biobank, and the Prospective Urban Rural Epidemiology study.

The Link Between Retinal Vessels and Heart Diseases

The analysis revealed that individuals with simpler and less branched retinal vessels were more likely to develop cardiovascular diseases. This group also showed biological signs of accelerated aging, including increased inflammation and reduced life expectancy. Currently, assessing aging-related conditions such as heart disease, stroke, and dementia typically requires multiple complex tests. Researchers hope that retinal imaging will simplify this process in the future, providing a quick and accessible measure for assessing aging and cardiovascular risk.

Uncovering Molecular Evidence Behind Aging

Deeper analysis of blood biomarkers and genetic data revealed biological mechanisms that may be responsible for these changes. Researchers identified several key proteins associated with inflammation and vascular aging, suggesting new pathways for drug development. Notable among these proteins were MMP12 and the IgG-Fc IIb receptor, both linked to age-related vascular damage.

Beiger explained that these molecules could be promising therapeutic targets. The findings point to potential drug targets for slowing vascular aging, reducing the burden of cardiovascular diseases, and improving life expectancy.

Conclusion

This study demonstrates the vast potential of using retinal scans as a non-invasive tool for assessing cardiovascular health and biological aging. Although further research is needed to confirm these findings and develop treatments based on them, a deeper understanding of molecular pathways could open new doors in preventive and therapeutic medicine. Support from prestigious health institutions underscores the importance of these findings and the need to continue exploration in this promising field.